share_log

Milestone Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Wills Robert James

SEC ·  Jun 10, 2023 04:23
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more